26 related articles for article (PubMed ID: 9635501)
1. Modification of cellular membrane functions by pendolmycin.
Umezawa K; Imoto M; Yamashita T; Sawa T; Takeuchi T
Jpn J Cancer Res; 1989 Jan; 80(1):15-8. PubMed ID: 2496055
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic-nuclear tumor promoter-specific binding protein: association with the 90 kDa heat shock protein and translocation into nuclei by treatment with 12-O-tetradecanoylphorbol 13-acetate.
Hashimoto Y; Shudo K
Jpn J Cancer Res; 1991 Jun; 82(6):665-75. PubMed ID: 1906853
[TBL] [Abstract][Full Text] [Related]
3. Pendolmycin, a new tumor promoter of the teleocidin A class on skin of CD-1 mice.
Nishiwaki S; Fujiki H; Yoshizawa S; Suganuma M; Furuya-Suguri H; Okabe S; Nakayasu M; Okabe K; Muratake H; Natsume M
Jpn J Cancer Res; 1991 Jul; 82(7):779-83. PubMed ID: 1908844
[TBL] [Abstract][Full Text] [Related]
4. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
[TBL] [Abstract][Full Text] [Related]
5. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
[TBL] [Abstract][Full Text] [Related]
7. Teleocidin from Streptomyces is a potent promoter of mouse skin carcinogenesis.
Fujiki H; Suganuma M; Matsukura N; Sugimura T; Takayama S
Carcinogenesis; 1982; 3(8):895-8. PubMed ID: 6812976
[TBL] [Abstract][Full Text] [Related]
8. Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.
Okabe S; Sueoka N; Komori A; Suganuma M; Endo Y; Shudo K; Fujiki H
Biol Pharm Bull; 1998 May; 21(5):465-8. PubMed ID: 9635501
[TBL] [Abstract][Full Text] [Related]
9. [The active conformation of teleocidins: design and synthesis of new active molecules].
Endo Y; Ohno M; Shudo K
Yakugaku Zasshi; 1994 Jul; 114(7):464-77. PubMed ID: 7932093
[TBL] [Abstract][Full Text] [Related]
10. Unique features of the okadaic acid activity class of tumor promoters.
Fujiki H; Suganuma M
J Cancer Res Clin Oncol; 1999; 125(3-4):150-5. PubMed ID: 10235468
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic Formation of Indolactam Scaffold by C-N Bond-Forming Cytochrome P450 Oxidases in Teleocidin Biosynthesis.
Morita I; Mori T; Abe I
Chemistry; 2021 Feb; 27(9):2963-2972. PubMed ID: 32996659
[TBL] [Abstract][Full Text] [Related]
12. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin.
Fujiki H; Sugimura T
Adv Cancer Res; 1987; 49():223-64. PubMed ID: 2890278
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
